Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.
Lancet Gastroenterol Hepatol
; 4(12): 960-970, 2019 12.
Article
in En
| MEDLINE
| ID: mdl-31494097
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-15
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
/
Guideline
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
/
Europa
Language:
En
Journal:
Lancet Gastroenterol Hepatol
Year:
2019
Document type:
Article
Country of publication:
Países Bajos